Home > Insider Trading > Filing (0001437749-15-020854)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1516479	Insys Therapeutics Inc.	INSY	Pharmaceutical Preparations (2834)	510327886

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1033150	N John Kapoor	444 South Ellis Street Chandler AZ 85224	President & Ceo	Yes	Yes	Yes	No
1575551	1989 20 September Dated Trust Kapoor N John	C/O Insys Therapeutics, Inc. 444 South Ellis Street Chandler AZ 85224		No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2015-11-12	1,500	$25.18	42,361,110	No	4	P	Indirect	By Trust
Common Stock	Acquisiton	2015-11-12	5,500	$26.58	42,366,610	No	4	P	Indirect	By Trust
Common Stock	Acquisiton	2015-11-12	3,000	$27.29	42,369,610	No	4	P	Indirect	By Trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By Trust
No	4	P	Indirect	By Trust
No	4	P	Indirect	By Trust

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	31,982	Direct
Common Stock	56,288	Indirect	By Partnership

Footnotes

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $24.95 to $25.57, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.
By The John N. Kapoor Trust dated September 20, 1989.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $25.97 to $26.89, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $27.09 to $27.41, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.
By EJ Financial/NEO Management, L.P. of which the reporting person is Managing General Partner.